IGC Projected Dividend Yield
IGC Pharma Inc ( AMEX : IGC )IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer's disease. Co.'s flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. Co. operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer's by targeting A? plaques, a key disease hallmark. Co.'s IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. 21 YEAR PERFORMANCE RESULTS |
IGC Dividend History Detail IGC Dividend News IGC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |